tricalcium phosphate has been researched along with clindamycin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Desai, TA; Uskoković, V | 2 |
Batarni, SS; Desai, TA; King, A; Schweicher, J; Uskoković, V | 1 |
Desai, TA; Hoover, C; Uskoković, DP; Uskoković, V; Vukomanović, M | 1 |
Bernstein, A; Bohner, M; Kuehling, T; Mayr, HO; Schilling, P; Seidenstuecker, M; Serr, A; Wittmer, A | 1 |
Bernstein, A; Bohner, M; Ritschl, L; Schilling, P; Schmal, H; Seidenstuecker, M; Wittmer, A | 1 |
6 other study(ies) available for tricalcium phosphate and clindamycin
Article | Year |
---|---|
Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Calcium Phosphates; Clindamycin; Delayed-Action Preparations; Humans; Mice; Nanoparticles; Osteoblasts; Osteomyelitis; Solubility; Staphylococcal Infections; Staphylococcus aureus | 2013 |
Effect of calcium phosphate particle shape and size on their antibacterial and osteogenic activity in the delivery of antibiotics in vitro.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Differentiation; Cell Line; Cell Survival; Clindamycin; Core Binding Factor Alpha 1 Subunit; Cytoskeleton; Delayed-Action Preparations; Durapatite; Mice; Microbial Sensitivity Tests; Osteoblasts; Osteocalcin; Osteogenesis; Osteopontin; Particle Size; Staphylococcus aureus | 2013 |
Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis.
Topics: Animals; Anti-Infective Agents; Calcium Phosphates; Cell Line; Clindamycin; Collagen Type I; Core Binding Factor Alpha 1 Subunit; Hydrogen-Ion Concentration; Lactic Acid; Mice; Nanoparticles; Osteoblasts; Osteocalcin; Osteogenesis; Osteomyelitis; Osteopontin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Staphylococcus aureus | 2013 |
Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Line; Cell Survival; Clindamycin; Cytoskeleton; Drug Carriers; Mice; Nanoparticles; Osteoblasts; Staphylococcus aureus | 2014 |
A human bone infection organ model for biomaterial research.
Topics: Alginates; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Calcium Phosphates; Clindamycin; Gelatin; Humans; Hydrogels; Osteomyelitis; Staphylococcus aureus | 2022 |
Composite material consisting of microporous beta-TCP ceramic and alginate-dialdehyde-gelatin for controlled dual release of clindamycin and bone morphogenetic protein 2.
Topics: Alginates; Animals; Bone Morphogenetic Protein 2; Capsules; Ceramics; Clindamycin; Gelatin; Humans; Hydrogels | 2023 |